146 related articles for article (PubMed ID: 20367108)
21. Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolites.
Dalvie D; Obach RS; Kang P; Prakash C; Loi CM; Hurst S; Nedderman A; Goulet L; Smith E; Bu HZ; Smith DA
Chem Res Toxicol; 2009 Feb; 22(2):357-68. PubMed ID: 19146377
[TBL] [Abstract][Full Text] [Related]
22. Estimating drug solubility in the gastrointestinal tract.
Dressman JB; Vertzoni M; Goumas K; Reppas C
Adv Drug Deliv Rev; 2007 Jul; 59(7):591-602. PubMed ID: 17599644
[TBL] [Abstract][Full Text] [Related]
23. An update on computational oral absorption simulation.
Dressman JB; Thelen K; Willmann S
Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1345-64. PubMed ID: 21939427
[TBL] [Abstract][Full Text] [Related]
24. Cunninghamella--a microbial model for drug metabolism studies--a review.
Asha S; Vidyavathi M
Biotechnol Adv; 2009; 27(1):16-29. PubMed ID: 18775773
[TBL] [Abstract][Full Text] [Related]
25. Predicting human pharmacokinetics from preclinical data.
Poggesi I
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):100-11. PubMed ID: 14982153
[TBL] [Abstract][Full Text] [Related]
26. Computational science in drug metabolism and toxicology.
Valerio LG
Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):781-4. PubMed ID: 20465524
[TBL] [Abstract][Full Text] [Related]
27. A structural feature-based computational approach for toxicology predictions.
Valerio LG; Yang C; Arvidson KB; Kruhlak NL
Expert Opin Drug Metab Toxicol; 2010 Apr; 6(4):505-18. PubMed ID: 20074001
[TBL] [Abstract][Full Text] [Related]
28. Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.
Lüpfert C; Reichel A
Chem Biodivers; 2005 Nov; 2(11):1462-86. PubMed ID: 17191947
[TBL] [Abstract][Full Text] [Related]
29. Alternative strategies in drug development: clinical pharmacological aspects.
Kuhlmann J
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
Kortejärvi H; Urtti A; Yliperttula M
Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
[TBL] [Abstract][Full Text] [Related]
31. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism.
Baillie TA
Chem Res Toxicol; 2008 Jan; 21(1):129-37. PubMed ID: 18052111
[TBL] [Abstract][Full Text] [Related]
32. Computational methods to predict the reactivity of nanoparticles through structure-property relationships.
Poater A; Gallegos Saliner A; Solà M; Cavallo L; Worth AP
Expert Opin Drug Deliv; 2010 Mar; 7(3):295-305. PubMed ID: 20201736
[TBL] [Abstract][Full Text] [Related]
33. Decontamination and detoxification strategies for the Fusarium mycotoxin deoxynivalenol in animal feed and the effectiveness of microbial biodegradation.
Awad WA; Ghareeb K; Bohm J; Zentek J
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2010 Apr; 27(4):510-20. PubMed ID: 20234966
[TBL] [Abstract][Full Text] [Related]
34. Probiotics, prebiotics, and synbiotics.
de Vrese M; Schrezenmeir J
Adv Biochem Eng Biotechnol; 2008; 111():1-66. PubMed ID: 18461293
[TBL] [Abstract][Full Text] [Related]
35. Early prediction of drug metabolism and toxicity: systems biology approach and modeling.
Bugrim A; Nikolskaya T; Nikolsky Y
Drug Discov Today; 2004 Feb; 9(3):127-35. PubMed ID: 14960390
[TBL] [Abstract][Full Text] [Related]
36. Human CYPs involved in drug metabolism: structures, substrates and binding affinities.
Lewis DF; Ito Y
Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):661-74. PubMed ID: 20402561
[TBL] [Abstract][Full Text] [Related]
37. Altered nonrenal drug clearance in ESRD.
Nolin TD
Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):555-9. PubMed ID: 18941346
[TBL] [Abstract][Full Text] [Related]
38. Predicting ADME properties and side effects: the BioPrint approach.
Krejsa CM; Horvath D; Rogalski SL; Penzotti JE; Mao B; Barbosa F; Migeon JC
Curr Opin Drug Discov Devel; 2003 Jul; 6(4):470-80. PubMed ID: 12951810
[TBL] [Abstract][Full Text] [Related]
39. Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: linear kinetics (I).
Fernández-Teruel C; Nalda Molina R; González-Alvarez I; Navarro-Fontestad C; García-Arieta A; Casabó VG; Bermejo M
Eur J Pharm Sci; 2009 Jan; 36(1):137-46. PubMed ID: 19028574
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]